Vascular access practices for therapeutic apheresis

Results of a survey

Yvette C. Tanhehco, Nicole D Zantek, Mohamed Alsammak, Vishesh Chhibber, Yanhua Li, Joanne Becker, Ding W. Wu, Tisha Foster, Gay Wehrli

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Introduction: Obtaining vascular access (VA) is a critical part of the therapeutic apheresis (TA) treatment plan. Currently, there are no guidelines for VA decision-making and maintenance related to TA procedures. Materials and Methods: A 28-question survey to gather qualitative information regarding VA practices was distributed to the American Society for Apheresis (ASFA) 2018 Annual Meeting attendees and all ASFA members for voluntary participation. The descriptive analyses were reported as the number and frequency of responses for each question. Results: Total participation was 206 with 147 (71.4%) answering some or all 16 VA focused questions. The majority of respondents were nurses or physicians (89.0%) at sites providing ≥100 procedures. The most common TA procedures were plasma exchange, red cell exchange, and leukocytapheresis. The VA evaluation was predominantly performed by the TA service (80.3%, 118/147). The majority of TA physicians and/or providers do not insert (91.7%, 132/144) or remove (81.2%, 117/143) VA catheters. When an emergent TA procedure is needed, the majority of respondents felt <2 hours was an acceptable turnaround time for VA placement (64.3%, 92/143). The most common anticoagulant for locking catheters and/or ports was heparin. The majority of TA services (54.3%, 76/140) collect data on aborted procedures due to catheter/line/port problems unrelated to infection, but only 41.4% (58/140) collect data on infections. Conclusion: VA contributes significantly to the overall risks associated with and the safety of TA. Our survey shows that there is substantial variation but common themes in TA VA practices. Several areas for future research may be identified.

Original languageEnglish (US)
Pages (from-to)571-578
Number of pages8
JournalJournal of clinical apheresis
Volume34
Issue number5
DOIs
StatePublished - Oct 1 2019

Fingerprint

Blood Component Removal
Blood Vessels
Vascular Access Devices
Therapeutics
Surveys and Questionnaires
Leukapheresis
Physicians
Plasma Exchange
Infection
Anticoagulants
Heparin
Decision Making
Nurses
Maintenance
Guidelines
Safety

Keywords

  • anticoagulant
  • catheter
  • peripheral veins
  • port
  • venous access

PubMed: MeSH publication types

  • Journal Article

Cite this

Tanhehco, Y. C., Zantek, N. D., Alsammak, M., Chhibber, V., Li, Y., Becker, J., ... Wehrli, G. (2019). Vascular access practices for therapeutic apheresis: Results of a survey. Journal of clinical apheresis, 34(5), 571-578. https://doi.org/10.1002/jca.21726

Vascular access practices for therapeutic apheresis : Results of a survey. / Tanhehco, Yvette C.; Zantek, Nicole D; Alsammak, Mohamed; Chhibber, Vishesh; Li, Yanhua; Becker, Joanne; Wu, Ding W.; Foster, Tisha; Wehrli, Gay.

In: Journal of clinical apheresis, Vol. 34, No. 5, 01.10.2019, p. 571-578.

Research output: Contribution to journalArticle

Tanhehco, YC, Zantek, ND, Alsammak, M, Chhibber, V, Li, Y, Becker, J, Wu, DW, Foster, T & Wehrli, G 2019, 'Vascular access practices for therapeutic apheresis: Results of a survey', Journal of clinical apheresis, vol. 34, no. 5, pp. 571-578. https://doi.org/10.1002/jca.21726
Tanhehco, Yvette C. ; Zantek, Nicole D ; Alsammak, Mohamed ; Chhibber, Vishesh ; Li, Yanhua ; Becker, Joanne ; Wu, Ding W. ; Foster, Tisha ; Wehrli, Gay. / Vascular access practices for therapeutic apheresis : Results of a survey. In: Journal of clinical apheresis. 2019 ; Vol. 34, No. 5. pp. 571-578.
@article{cf6a3ebfaed248e79bb41cc9e93e210f,
title = "Vascular access practices for therapeutic apheresis: Results of a survey",
abstract = "Introduction: Obtaining vascular access (VA) is a critical part of the therapeutic apheresis (TA) treatment plan. Currently, there are no guidelines for VA decision-making and maintenance related to TA procedures. Materials and Methods: A 28-question survey to gather qualitative information regarding VA practices was distributed to the American Society for Apheresis (ASFA) 2018 Annual Meeting attendees and all ASFA members for voluntary participation. The descriptive analyses were reported as the number and frequency of responses for each question. Results: Total participation was 206 with 147 (71.4{\%}) answering some or all 16 VA focused questions. The majority of respondents were nurses or physicians (89.0{\%}) at sites providing ≥100 procedures. The most common TA procedures were plasma exchange, red cell exchange, and leukocytapheresis. The VA evaluation was predominantly performed by the TA service (80.3{\%}, 118/147). The majority of TA physicians and/or providers do not insert (91.7{\%}, 132/144) or remove (81.2{\%}, 117/143) VA catheters. When an emergent TA procedure is needed, the majority of respondents felt <2 hours was an acceptable turnaround time for VA placement (64.3{\%}, 92/143). The most common anticoagulant for locking catheters and/or ports was heparin. The majority of TA services (54.3{\%}, 76/140) collect data on aborted procedures due to catheter/line/port problems unrelated to infection, but only 41.4{\%} (58/140) collect data on infections. Conclusion: VA contributes significantly to the overall risks associated with and the safety of TA. Our survey shows that there is substantial variation but common themes in TA VA practices. Several areas for future research may be identified.",
keywords = "anticoagulant, catheter, peripheral veins, port, venous access",
author = "Tanhehco, {Yvette C.} and Zantek, {Nicole D} and Mohamed Alsammak and Vishesh Chhibber and Yanhua Li and Joanne Becker and Wu, {Ding W.} and Tisha Foster and Gay Wehrli",
year = "2019",
month = "10",
day = "1",
doi = "10.1002/jca.21726",
language = "English (US)",
volume = "34",
pages = "571--578",
journal = "Journal of Clinical Apheresis",
issn = "0733-2459",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Vascular access practices for therapeutic apheresis

T2 - Results of a survey

AU - Tanhehco, Yvette C.

AU - Zantek, Nicole D

AU - Alsammak, Mohamed

AU - Chhibber, Vishesh

AU - Li, Yanhua

AU - Becker, Joanne

AU - Wu, Ding W.

AU - Foster, Tisha

AU - Wehrli, Gay

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Introduction: Obtaining vascular access (VA) is a critical part of the therapeutic apheresis (TA) treatment plan. Currently, there are no guidelines for VA decision-making and maintenance related to TA procedures. Materials and Methods: A 28-question survey to gather qualitative information regarding VA practices was distributed to the American Society for Apheresis (ASFA) 2018 Annual Meeting attendees and all ASFA members for voluntary participation. The descriptive analyses were reported as the number and frequency of responses for each question. Results: Total participation was 206 with 147 (71.4%) answering some or all 16 VA focused questions. The majority of respondents were nurses or physicians (89.0%) at sites providing ≥100 procedures. The most common TA procedures were plasma exchange, red cell exchange, and leukocytapheresis. The VA evaluation was predominantly performed by the TA service (80.3%, 118/147). The majority of TA physicians and/or providers do not insert (91.7%, 132/144) or remove (81.2%, 117/143) VA catheters. When an emergent TA procedure is needed, the majority of respondents felt <2 hours was an acceptable turnaround time for VA placement (64.3%, 92/143). The most common anticoagulant for locking catheters and/or ports was heparin. The majority of TA services (54.3%, 76/140) collect data on aborted procedures due to catheter/line/port problems unrelated to infection, but only 41.4% (58/140) collect data on infections. Conclusion: VA contributes significantly to the overall risks associated with and the safety of TA. Our survey shows that there is substantial variation but common themes in TA VA practices. Several areas for future research may be identified.

AB - Introduction: Obtaining vascular access (VA) is a critical part of the therapeutic apheresis (TA) treatment plan. Currently, there are no guidelines for VA decision-making and maintenance related to TA procedures. Materials and Methods: A 28-question survey to gather qualitative information regarding VA practices was distributed to the American Society for Apheresis (ASFA) 2018 Annual Meeting attendees and all ASFA members for voluntary participation. The descriptive analyses were reported as the number and frequency of responses for each question. Results: Total participation was 206 with 147 (71.4%) answering some or all 16 VA focused questions. The majority of respondents were nurses or physicians (89.0%) at sites providing ≥100 procedures. The most common TA procedures were plasma exchange, red cell exchange, and leukocytapheresis. The VA evaluation was predominantly performed by the TA service (80.3%, 118/147). The majority of TA physicians and/or providers do not insert (91.7%, 132/144) or remove (81.2%, 117/143) VA catheters. When an emergent TA procedure is needed, the majority of respondents felt <2 hours was an acceptable turnaround time for VA placement (64.3%, 92/143). The most common anticoagulant for locking catheters and/or ports was heparin. The majority of TA services (54.3%, 76/140) collect data on aborted procedures due to catheter/line/port problems unrelated to infection, but only 41.4% (58/140) collect data on infections. Conclusion: VA contributes significantly to the overall risks associated with and the safety of TA. Our survey shows that there is substantial variation but common themes in TA VA practices. Several areas for future research may be identified.

KW - anticoagulant

KW - catheter

KW - peripheral veins

KW - port

KW - venous access

UR - http://www.scopus.com/inward/record.url?scp=85068598037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068598037&partnerID=8YFLogxK

U2 - 10.1002/jca.21726

DO - 10.1002/jca.21726

M3 - Article

VL - 34

SP - 571

EP - 578

JO - Journal of Clinical Apheresis

JF - Journal of Clinical Apheresis

SN - 0733-2459

IS - 5

ER -